The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
329.90
0.00 (0.00%)
At close: Feb 26, 2026
13.25%
Market Cap 10.31B
Revenue (ttm) 13.42B
Net Income (ttm) 815.70M
Shares Out 31.24M
EPS (ttm) 26.11
PE Ratio 12.64
Forward PE n/a
Dividend 6.40 (1.94%)
Ex-Dividend Date Oct 27, 2025
Volume 150,461
Average Volume 154,479
Open 330.00
Previous Close 329.90
Day's Range 328.60 - 332.50
52-Week Range 273.80 - 371.00
Beta 0.18
RSI 45.32
Earnings Date Jan 26, 2026

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Employees 5,200
Stock Exchange Dhaka Stock Exchange
Ticker Symbol IBNSINA
Full Company Profile

Financial Performance

In fiscal year 2025, DSE:IBNSINA's revenue was 11.88 billion, an increase of 4.51% compared to the previous year's 11.37 billion. Earnings were 633.19 million, a decrease of -5.57%.

Financial Statements

News

There is no news available yet.